PMID- 31400204
OWN - NLM
STAT- MEDLINE
DCOM- 20200521
LR  - 20200521
IS  - 1460-2393 (Electronic)
IS  - 1460-2393 (Linking)
VI  - 112
IP  - 12
DP  - 2019 Dec 1
TI  - Drug rash vs. immune reconstitution inflammatory syndrome (IRIS)-a diagnostic 
      dilemma.
PG  - 925-926
LID - 10.1093/qjmed/hcz214 [doi]
FAU - Gupta, N
AU  - Gupta N
AD  - Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, 
      New Delhi, Delhi, India.
FAU - Mittal, A
AU  - Mittal A
AD  - Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, 
      New Delhi, Delhi, India.
FAU - Nischal, N
AU  - Nischal N
AD  - Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, 
      New Delhi, Delhi, India.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - England
TA  - QJM
JT  - QJM : monthly journal of the Association of Physicians
JID - 9438285
RN  - V83O1VOZ8L (Isoniazid)
SB  - IM
MH  - Adult
MH  - Antiretroviral Therapy, Highly Active
MH  - CD4 Lymphocyte Count
MH  - Diagnosis, Differential
MH  - Exanthema/*etiology
MH  - HIV Infections/*complications/drug therapy
MH  - Humans
MH  - Immune Reconstitution Inflammatory Syndrome/*chemically 
      induced/*etiology/physiopathology
MH  - Isoniazid/*adverse effects
MH  - Male
MH  - Scabies/complications/diagnosis
EDAT- 2019/08/11 06:00
MHDA- 2020/05/22 06:00
CRDT- 2019/08/11 06:00
PHST- 2019/08/02 00:00 [received]
PHST- 2019/08/06 00:00 [revised]
PHST- 2019/08/11 06:00 [pubmed]
PHST- 2020/05/22 06:00 [medline]
PHST- 2019/08/11 06:00 [entrez]
AID - 5545980 [pii]
AID - 10.1093/qjmed/hcz214 [doi]
PST - ppublish
SO  - QJM. 2019 Dec 1;112(12):925-926. doi: 10.1093/qjmed/hcz214.